Ajanta Pharma, a mid-cap pharma player with strong branded generics in ophthalmology, dermatology, and cardiology, is showing a compelling swing trade setup backed by a high-probability technical breakout.
Reasons are listed below :
Target - 3080 // 3400
Stoploss - weekly close below 2415
DISCLAIMER -
Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services.
@visionary.growth.insights
Reasons are listed below :
- Bullish engulfing candle on the weekly timeframe, indicating reversal strength
- 2,500 zone acting as a crucial support
- Holding above 0.382 Fibonacci retracement level, suggesting healthy correction
- Price trading above 50 & 200 EMA on the weekly chart – long-term strength intact
- Breakout from narrow consolidation near the 50-week EMA
Target - 3080 // 3400
Stoploss - weekly close below 2415
DISCLAIMER -
Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services.
@visionary.growth.insights
Catatan
3%+ from buying price;upside momentum shall continue
Catatan
hold, momentum is picking up!Catatan
back to buying price; might add on some quantity if it dipsCatatan
hold!Catatan
Weekly close above 2800 will trigger some upmove!Catatan
stay cautious!trading near SL
Catatan
bounced back from the support zone;still in the consolidation range, hold!
Catatan
bounced back from 2500 levels; holdCatatan
still consolidating, hold!
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.